---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-079340"
form_type: "8-K"
ticker: "VYGR"
cik: "0001640266"
company_name: "Voyager Therapeutics, Inc."
filed_at: "2023-07-10T23:59:59+00:00"
generated_at: "2026-06-13T10:35:54.542976+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Voyager Therapeutics appoints Jacquelyn Fahey Sandell as Chief Legal Officer

## Summary
- Jacquelyn Fahey Sandell named CLO effective July 10, 2023; reports to CEO Alfred Sandrock.
- Base salary of $450,000 per year; eligible for annual cash bonus at 40% of base salary target.
- Inducement equity grant: option to purchase 122,000 shares (4-year vest) and RSU for 61,000 shares (3-year vest).
- Severance includes 12 months base salary, pro-rata target bonus, COBRA subsidy, and full equity acceleration upon qualifying termination within 12 months of a sale event.

## SEC filing metadata
- accession: 0001104659-23-079340
- form_type: 8-K
- ticker: VYGR
- cik: 0001640266
- company_name: Voyager Therapeutics, Inc.
- filed_at: 2023-07-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/0001104659-23-079340-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1640266/000110465923079340/tm2320812d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-079340
- JSON: https://secwatch.observer/filing/0001104659-23-079340.json
- Plain text: https://secwatch.observer/filing/0001104659-23-079340.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.